ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$0.84
+0.10 (+13.16%)
As of Nov 18, 10:10 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,619.4% upside
Low Target $8.98
Average Target $14.46
High Target $17.59
Current Price $0.84
Current
$0.84
Target
$14.46
$8.98 $14.46 avg $17.59
Scenario Analysis
Bear Case
$8.98
967.8%
Low target
Base Case
$14.46
+1,619.4%
Avg target
Bull Case
$17.59
+1,991.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.50
-84.7% from high
52-Week Low
$0.62
+36.5% from low
Target vs 52W High
$14.46
+162.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -9.9%
AMGN
Amgen Inc
Hold 42 43% $190.87 -57.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.3%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -24.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.6%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -28.6%